The criticism of vaccine manufacturer AstraZeneca is increasing.
World Medical President Montgomery has now expressed himself.
A politician calls for a new vaccination sequence.
World medical president Montgomery criticized
vaccine manufacturer AstraZeneca
(see first report).
A new corona * vaccine is said to be almost 90 percent effective.
Meanwhile, SPD leader Saskia Esken called for a change in the vaccination sequence in Germany.
This news ticker is updated regularly.
Update from January 29, 2:15 p.m.:
The EU Commission published its framework agreement with the
pharmaceutical company AstraZeneca
on Friday
.
However, important passages of the document have been redacted with reference to trade secrets.
This also includes the delivery quantities planned for the first quarter.
This caused harsh criticism of AstraZeneca
(see first report).
The EU Commission welcomed the company's willingness to be more transparent.
This is important to build trust among Europeans and ensure that they can rely on the effectiveness and safety of
corona vaccines
in the EU.
The Commission hopes to be able to publish all contracts with vaccine manufacturers.
Corona in Germany: 2.2 percent of the total population received the first vaccination
In Germany, 1,799,481 people have received their
first vaccination
since the start of the corona
vaccination
.
That corresponds to 2.2 percent of the total population.
416,646 people already received the second vaccination.
On January 28, 94,112 vaccinations were carried out in Germany (data status: January 29, 10:50 a.m.).
“Underground!” World Medical Director Montgomery railed - is there a new vaccination sequence in Germany?
Our first report from January 29th:
Munich - “The behavior of AstraZeneca is underground,” said
World Medical President Frank Ulrich Montgomery
to the editorial network Germany (RND).
The corona infection and death rates are still at a high level.
Last but not least, different virus variants are causing a stir.
The vaccine is one of the high hopes in the pandemic.
But vaccine
manufacturer AstraZeneca in
particular
has received a lot of criticism.
Vaccine maker AstraZeneca under fire - Montgomery calls for export ban
On Friday (January 29), the
AstraZeneca
vaccine,
the
third corona vaccine *
, is to be approved by the European Medicines Agency (EMA).
It follows the vaccines from
Biontech / Pfizer *
and
Moderna
.
But AstraZeneca is heavily criticized across Europe.
The background: of the 80 million cans originally promised for Europe, only 31 million are to be delivered.
“It cannot be that the company keeps its delivery promises for Great Britain exactly”, criticized Montgomery and continued, “but only delivers a fraction of the promised vaccination doses for the EU.” The world medical chief told RND: “If the vaccine is on continental European Soil is produced, you have to give the company
forbid extraditing him outside the EU. "
Von der Leyen criticizes vaccine manufacturers - contract with companies to be published
EU Commission President
Ursula von der Leyen
also accused AstraZeneca of failing to keep the delivery commitments.
The EU's contract with the company was “crystal clear” and “clear delivery quantities” had been agreed, the politician said on Friday on Deutschlandfunk.
To prove this, the contract should be published as soon as possible.
AstraZeneca boss Pascal Soriot
justified the delays with the fact that the EU concluded its supply contract three months later than Great Britain.
In addition, his company has not committed itself to fixed delivery quantities, but only to "do your best" as part of a so-called "best effort clause".
Von der Leyen confirmed that there was such a clause in the contract, but it only applied for the time the
vaccine was being developed
.
“That time is behind us, the vaccine is here.” In addition, the vaccine manufacturer had given assurances “that no other obligations would prevent the fulfillment of this contract” - and therefore no earlier contract with Great Britain.
Vaccine debate in Germany: Esken calls for a new sequence of vaccines
Meanwhile, another critical point about AstraZeneca's vaccine is causing a stir.
In Germany, the drug is expected to be administered only to people under 65 years of age.
This emerged from a recommendation by the Standing Vaccination Commission (Stiko).
The committee justified this by stating that “currently insufficient data” are available to assess the effectiveness of the product in people aged 65 and over.
In view of this, SPD leader
Saskia Esken
demanded
consequences.
"We now have to immediately procure alternative vaccines for people over 65 and, on the other hand,
re-coordinate
the
vaccination sequence
for the AstraZeneca vaccine that will arrive shortly," Esken told the newspapers of the Funke media group.
“Above all, hospital and nursing staff should be the first to benefit from the resources that are now available,” she demanded.
New vaccine from US manufacturer - effectiveness of almost 90 percent
Another
vaccine manufacturer
has reported success in the
fight against the coronavirus
.
The US pharmaceutical company
Novavax
has announced a high rate of effectiveness of its corona vaccine candidate.
As the company announced on Thursday, the agent had shown an effectiveness of 89.3 percent in the third and final study phase in test subjects in Great Britain.
The vaccine is also said to be effective
against the
virus mutations *
, but to varying degrees.
The EU is also considering supply by
Novavax
.
Like AstraZeneca, the compound has the advantage that it does not have to be stored at temperatures as low as the vaccines from Biontech / Pfizer and Moderna.
Meanwhile, RKI boss Wieler said on Friday: "The more we vaccinate, the more mutations will occur."
* Merkur.de is part of the nationwide Ippen digital editorial network (dpa / mbr)
